Company · CIK 1302573
OncoMed Pharmaceuticals Inc
| CIK | 1302573 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2013-09-03 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-225225 | 2018-05-25 | 2018-06-19 | 2 | |
| 333-204914 | 2015-06-12 | 2016-08-19 | 4 | |
| 333-181331 | 2012-05-11 | 2013-07-18 | 13 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2018-06-19 | EFFECTDeclared effective | 333-225225 | 9999999995-18-001536 |
| 2018-05-25 | S-3Shelf registered | 333-225225 | 0001193125-18-175282 |
| 2016-08-19 | 424B5Shelf takedown | 333-204914 | 0001193125-16-686553 |
| 2016-08-17 | 424B5Shelf takedown | 333-204914 | 0001193125-16-684104 |
| 2015-07-22 | EFFECTDeclared effective | 333-204914 | 9999999995-15-002019 |
| 2015-06-12 | S-3Shelf registered | 333-204914 | 0001193125-15-221877 |
| 2013-07-18 | 424B4Final prospectus | 333-181331 | 0001193125-13-293600 |
| 2013-07-17 | EFFECTDeclared effective | 333-181331 | 9999999995-13-002100 |
| 2013-07-17 | S-1/AAmendment | 333-181331 | 0001193125-13-292343 |
| 2013-07-08 | S-1/AAmendment | 333-181331 | 0001193125-13-284098 |
| 2013-07-03 | S-1/AAmendment | 333-181331 | 0001193125-13-281668 |
| 2013-06-24 | S-1/AAmendment | 333-181331 | 0001193125-13-267814 |
| 2013-04-02 | S-1/AAmendment | 333-181331 | 0001193125-13-138775 |
| 2012-12-03 | S-1/AAmendment | 333-181331 | 0001193125-12-487919 |
| 2012-10-25 | S-1/AAmendment | 333-181331 | 0001193125-12-433969 |
| 2012-07-05 | S-1/AAmendment | 333-181331 | 0001193125-12-294963 |
| 2012-07-03 | S-1/AAmendment | 333-181331 | 0001193125-12-293896 |
| 2012-06-15 | S-1/AAmendment | 333-181331 | 0001193125-12-272260 |
| 2012-05-11 | S-1Registration filed | 333-181331 | 0001193125-12-227061 |